Rethinking the Protein Inhibitor Approach to Cancer Therapy
Stony Brook UniversityA new method than enables researchers to dial up or tone down the amount of a certain metastatic protein inhibitor (BACH1) within a cell could provide a new path in cancer research that reassesses the effectiveness of protein inhibitors to treat disease.